Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vosilasarm - Ellipses Pharma

Next Previous
Drug Profile

Vosilasarm - Ellipses Pharma

Alternative Names: EP-0062; RAD-140; Testolone - Radius Health

Latest Information Update: 22 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Radius
  • Developer Ellipses Pharma; Radius Health Inc.
  • Class Amines; Antineoplastics; Chlorobenzenes; Nitriles; Osteoporosis therapies; Oxadiazoles; Small molecules
  • Mechanism of Action Selective androgen receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II HER2 negative breast cancer
  • Discontinued Osteoporosis; Sarcopenia

Most Recent Events

  • 11 Jan 2023 Phase-I/II clinical trials in HER2-negative-breast-cancer (Second-line therapy or greater, Late-stage disease, Metastatic disease) in United Kingdom, Spain (PO) (NCT05573126)
  • 05 Dec 2022 Phase-I/II clinical trials in HER2-negative-breast-cancer (Late-stage disease, Metastatic disease, Second-line therapy or greater) in USA (PO) (NCT05573126)
  • 17 Oct 2022 Phase-I clinical trials in Breast cancer (Late-stage disease, Metastatic disease) in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top